Multifocal Evanescent White Dot Syndrome-like Phenotypes Associated with Inflammatory and Myopic Choroidal Neovascularization
PURPOSE: To present the observation of multifocal evanescent white dot syndrome (MEWDS)-like phenotypes developing in association with the onset of choroidal neovascularization (CNV) in a series of patients.
METHODS: Patients presenting to tertiary-care centers with MEWDS-like phenotypes and CNV were identified.
RESULTS: Five patients presented for the management of CNV in the context of previous diagnoses of punctate inner choroidopathy (PIC) and/or myopia. In time-periods ranging from 0 days to 12 weeks from the diagnosis of active CNV, MEWDS-like changes were observed. Treatment with anti-VEGF agents were instituted in four cases, in an as-required protocol. 1 patient received systemic steroid.
CONCLUSIONS: The development of MEWDS-like phenotypes in association with CNVM can occur in eyes with either inflammatory or non-inflammatory CNVM, and in those who were or were not treated with anti-VEGF therapy. The association suggests an inflammatory event, which causes RPE changes and probably induces the development of the CNV.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - 30(2022), 7-8 vom: 14. Okt., Seite 1707-1714 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Burke, Tomas R [VerfasserIn] |
---|
Links: |
---|
Themen: |
Autoflurescence |
---|
Anmerkungen: |
Date Completed 15.12.2022 Date Revised 15.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09273948.2021.1936563 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326728538 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326728538 | ||
003 | DE-627 | ||
005 | 20231225195226.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2021.1936563 |2 doi | |
028 | 5 | 2 | |a pubmed24n1089.xml |
035 | |a (DE-627)NLM326728538 | ||
035 | |a (NLM)34124984 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Burke, Tomas R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multifocal Evanescent White Dot Syndrome-like Phenotypes Associated with Inflammatory and Myopic Choroidal Neovascularization |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.12.2022 | ||
500 | |a Date Revised 15.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE: To present the observation of multifocal evanescent white dot syndrome (MEWDS)-like phenotypes developing in association with the onset of choroidal neovascularization (CNV) in a series of patients | ||
520 | |a METHODS: Patients presenting to tertiary-care centers with MEWDS-like phenotypes and CNV were identified | ||
520 | |a RESULTS: Five patients presented for the management of CNV in the context of previous diagnoses of punctate inner choroidopathy (PIC) and/or myopia. In time-periods ranging from 0 days to 12 weeks from the diagnosis of active CNV, MEWDS-like changes were observed. Treatment with anti-VEGF agents were instituted in four cases, in an as-required protocol. 1 patient received systemic steroid | ||
520 | |a CONCLUSIONS: The development of MEWDS-like phenotypes in association with CNVM can occur in eyes with either inflammatory or non-inflammatory CNVM, and in those who were or were not treated with anti-VEGF therapy. The association suggests an inflammatory event, which causes RPE changes and probably induces the development of the CNV | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multifocal eveanescent white dot syndrome | |
650 | 4 | |a autoflurescence | |
650 | 4 | |a choroidal neovascularization | |
700 | 1 | |a Addison, Peter K F |e verfasserin |4 aut | |
700 | 1 | |a Pavesio, Carlos E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g 30(2022), 7-8 vom: 14. Okt., Seite 1707-1714 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2022 |g number:7-8 |g day:14 |g month:10 |g pages:1707-1714 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2021.1936563 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2022 |e 7-8 |b 14 |c 10 |h 1707-1714 |